Optimizing multiple myeloma treatment Jesús San Miguel, MD, PhD, University of Navarra Clinic, Pamplona, Spain, talks on the importance of having access to optimal tools, such as measurable …

Read More

Daratumumab in the treatment of multiple myeloma Paul Richardson, MD, from the Dana-Farber Cancer Institute, Boston, MA, discusses the use of daratumumab in the treatment of multiple myeloma at the 2017 British Society for Haematology (BSH) Annual Scientific Meeting in Brighton, UK. Daratumumab is the frontline in monoclonal antibody treatment in multiple myeloma. It is […]

Read More